Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis

Kater A., Panagiotis P., Aktan M. , ARSLAN Ö., DEMİRKAN F., Enggaard L., ...More

LEUKEMIA & LYMPHOMA, vol.61, pp.113-115, 2020 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 61
  • Publication Date: 2020
  • Title of Journal : LEUKEMIA & LYMPHOMA
  • Page Numbers: pp.113-115